Intended Use

The VUNO Med-DeepBrain is intended for automatic labeling, quantification and visualization of segmentable brain structures from a set of MR images.

Technology

The software uses deep learning to automatically segment brain structures and lesions from 3D T1 and 2D T2 FLAIR MR images. It provides volumetric quantification, visual color maps, and integrates with PACS through DICOM. Pre-processing steps include resampling, registration, bias-field correction, and brain extraction; post-processing includes outlier removal and quality control.

Performance

Performance tests include segmentation accuracy measured by Dice Similarity Coefficient exceeding acceptance criteria of 0.80, and volume error analysis showing low errors in key brain regions. Reproducibility testing achieved high intraclass correlation coefficients, demonstrating excellent reliability. The device passed all pre-determined acceptance criteria, indicating safety and effectiveness comparable to the predicate device.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    5/15/2023

    4 months
  • 2

    FDA Approval

    10/4/2023

Other devices from VUNO Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.